[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Astrazeneca Plc 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA GBR

https://www.astrazeneca.com P: 203-749-5000 F: 122-335-2858

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Key Statistics

Overview:

Market Capitalization, $K 216,434,292
Shares Outstanding, K 1,550,833
% of Insider Shareholders 0.15%
% of Institutional Shareholders 67.75%

Financials:

Annual Sales, $ 58,739 M
Annual Net Income, $ 10,225 M
Last Quarter Sales, $ 15,503 M
Last Quarter Net Income, $ 2,326 M

Growth:

1-Year Return 32.46%
3-Year Return 18.81%
5-Year Return 80.80%
5-Year Revenue Growth 17.15%
5-Year Earnings Growth 21.80%
5-Year Dividend Growth 2.23%

Per-Share Information:

Most Recent Earnings 1.49 on 02/10/26
Next Earnings Date N/A
Earnings Per Share ttm 6.54
EPS Growth vs. Prev Qtr -8.02%
EPS Growth vs. Prev Year 45.23%
Annual Dividend & Yield (Paid) 3.13 (1.69%)
Annual Dividend & Yield (Fwd) 3.19 (1.69%)
Most Recent Dividend 1.595 on 02/19/26
Next Ex-Dividends Date 02/19/26
Dividend Payable Date 03/23/26
Dividend Payout Ratio 47.91%

AZN.LN Ratios

Ratio
Price/Earnings ttm 28.73
Price/Earnings forward 17.99
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 17.41%
Debt/Equity 0.54
Price/Sales 5.00
Price/Book N/A
Book Value/Share N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.